MDxHealth Named Euronext Best BEL Small Company Performer for 2014
"We are honoured to receive this prestigious award from Euronext and we would like to thank MDxHealth shareholders, scientific collaborators, the medical community, and reimbursement organizations who have supported and entrusted the Company so far," stated Dr. Groen. "Several significant milestones were achieved during 2014 and with broader market adoption of our ConfirmMDx test and increasing reimbursement coverage, we are well-positioned for a strong 2015."
The BEL Small Cap Award is supported by Euronext Brussels, and has established itself as a showcase for the best performing companies within the Belgium small-cap market, providing an opportunity to recognize outstanding achievement.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.